The Efficacy of Evening Primrose in Rheumatoid Arthritis: a Systematic Review

Document Type : Review

Authors

1 Department of Biology, Concordia University, Montreal, Canada.

2 Department of Immunology, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.

3 Department of Immunology, School of Medicine, Qazvin University of Medical Sciences, Qazvin, Iran.

10.22127/rjp.2023.414090.2212

Abstract

Considering the different side effects of the long-time conventional anti-rheumatic drugs prescribed for the treatment of rheumatoid arthritis, numerous studies have focused on herbal medicines to reduce inflammation in autoimmune diseases. Although the beneficial properties of evening primrose on rheumatoid arthritis have been determined, the results of the studies have not been systematically reported. The present review has investigated the effects of evening primrose on rheumatoid arthritis systematically. We searched the following electronic databases until March 2023: PubMed, the Cochrane Library, the China National Knowledge Infrastructure, Scopus, ProQuest, Google Scholar electronic databases, allied and complementary medicine database (AMED), and scientific information database (SID) databases for relevant studies. We excluded non-English articles and those not meeting our criteria. We chose all of the correlated original clinical, animal, and in vitro studies. Each article was assessed critically for the possible risk of bias. Thirteen articles were analyzed. Animal and in vitro research confirmed the desired effects of evening primrose on clinical, inflammatory, oxidative, and immunologic factors in rheumatoid arthritis. Also, the results of clinical studies showed the change and improvement of inflammatory and oxidative biomarkers in rheumatoid arthritis. Evening primrose could control rheumatoid arthritis in multiple ways such as decreasing inflammation, inhibiting oxidative stress, and modulating the immune system. This article provides convincing evidence to support the efficacy of evening primrose in rheumatoid arthritis and explains the significance of future clinical trials. Further large-scale high-quality randomized controlled trials (RCTs) assessing the efficacy of evening primrose on rheumatoid arthritis as a primary outcome variable are recommended.

Keywords

Main Subjects

References

  • Souza PR, Norling LV. Implications for eicosapentaenoic acid-and docosahexaenoic acid-derived resolvins as therapeutics for arthritis. Eur J Pharmacol. 2016; 785: 165-173.
  • Guo Q, Wang Y, Xu D, Nossent J, Pavlos NJ, Xu J. Rheumatoid arthritis: pathological mechanisms and modern pharmacologic therapies. Bone Res. 2018; 6(1): 1-14.
  • Lajas C, Abasolo L, Bellajdel B, Hernández‐García C, Carmona L, Vargas E, Lázaro P, Jover JA. Costs and predictors of costs in rheumatoid arthritis: a prevalence‐based study. Arthritis Rheum. 2003; 49(1): 64-70.
  • Choy E. Understanding the dynamics: pathways involved in the pathogenesis of rheumatoid arthritis. Rheumatology. 2012; 51(S5): 3-11.
  • Kumar P, Banik S. Pharmacotherapy options in rheumatoid arthritis. Clin Med Insights Arthritis Musculoskelet Disord. 2013; 6: 35-43.
  • Kadhim M, Kaizal A, Hameed I. Medicinal plants used for treatment of rheumatoid arthritis: a review. Int J Pharm Clin Res. 2016; 8(12): 1685-1694.
  • World Health Organization. WHO guidelines on safety monitoring of herbal medicines in pharmacovigilance systems. Geneva: World Health Organization, 2004.
  • Tracy TS, Kingston RL. Herbal products: toxicology and clinical pharmacology. Totowa: Humana, 2007.
  • Mahboubi M. Evening primrose (Oenothera biennis) oil in management of female ailments. J Menopausal Med. 2019; 25(2): 74-82.
  • Safaa Hussain M, Abdulridha MK, Khudhair MS. Anti-inflammatory, anti-oxidant, and vasodilating effect of evening primrose oil in type 2 diabetic patients. Int J Pharm Sci Rev Res. 2016; 39(2): 173-178.
  • Zeng G, Ju Y, Shen H, Zhou N, Huang L. Immunopontentiating activities of the purified polysaccharide from evening primrose in H22 tumor-bearing mice. Int J Biol Macromol. 2013; 52: 280-285.
  • Munir R, Semmar N, Farman M, Ahmad NS. An updated review on pharmacological activities and phytochemical constituents of evening primrose (genus Oenothera). Asian Pac J Trop Biomed. 2017; 7(11): 1046-1054.
  • Abd-Nikfarjam B, Abbasi M, Memarzadeh M, Farzam SA, Jamshidian A, Dolati-Somarin A. Therapeutic efficacy of Urtica dioica and evening primrose in patients with rheumatoid arthritis: a randomized double-blind, placebo-controlled clinical trial. J Herb Med. 2022; 32: 1-20.
  • Tomic-Smiljanic M, Vasiljevic D, Lucic-Tomic A, Andjelkovic N, Jakovljevic V, Bolovich S, Veselinovic M. Influence of different supplementation on platelet aggregation in patients with rheumatoid arthritis. Clin Rheumatol. 2019; 38: 2443-2450.
  • Veselinovic M, Vasiljevic D, Vucic V, Arsic A, Petrovic S, Tomic-Lucic A, Savic M, Zivanovic S, Stojic V, Jakovljevic V. Clinical benefits of n-3 PUFA and ɤ-linolenic acid in patients with rheumatoid arthritis. Nutrients. 2017; 9(4): 1-11.
  • Vasiljevic D, Veselinovic M, Jovanovic M, Jeremic N, Arsic A, Vucic V, Lucic-Tomic A, Zivanovic S, Djuric D, Jakovljevic V. Evaluation of the effects of different supplementation on oxidative status in patients with rheumatoid arthritis. Clin Rheumatol. 2016; 35(8): 1909-1915.
  • Sahar YAO, Nagwa MA, Kh AS, Doha AM. Impact of natural oils supplements on disease activity and antioxidant state of Egyptian patients with rheumatoid arthritis. Med J Islamic World Acad Sci. 2000; 13(4): 161-171.
  • Brzeski M, Madhok R, Capell H. Evening primrose oil in patients with rheumatoid arthritis and side-effects of non-steroidal anti-inflammatory drugs. Rheumatology. 1991; 30(5): 370-372.
  • Jäntti J, Nikkari T, Solakivi T, Vapaatalo H, Isomäki H. Evening primrose oil in rheumatoid arthritis: changes in serum lipids and fatty acids. Ann Rheum Dis. 1989; 48(2): 124-127.
  • Jäntti J, Seppälä E, Vapaatalo H, Isomäki H. Evening primrose oil and olive oil in treatment of rheumatoid arthritis. Clin Rheumatol. 1989; 8(2): 238-244.
  • Belch J, Ansell D, Madhok R, O'dowd A, Sturrock R. Effects of altering dietary essential fatty acids on requirements for non-steroidal anti-inflammatory drugs in patients with rheumatoid arthritis: a double blind placebo controlled study. Ann Rheum Dis. 1988; 47(2): 96-104.
  • Mahmoud B, Ebrahim S, Kandeil M. Anti-inflammatory effects of evening primrose and extra virgin olive oil on arthritc rats. Adv Anim Vet Sci. 2021; 9(10): 1684-1691.
  • El-Sayed R, Moustafa Y, El-Azab M. Evening primrose oil and celecoxib inhibited pathological angiogenesis, inflammation, and oxidative stress in adjuvant-induced arthritis: novel role of angiopoietin-1. Inflammopharmacology. 2014; 22(5): 305-317.
  • Montserrat-De La Paz S, García-Giménez M, Ángel-Martín M, Pérez-Camino M, Arche AF. Long-chain fatty alcohols from evening primrose oil inhibit the inflammatory response in murine peritoneal macrophages. J Ethnopharmacol. 2014; 151(1): 131-136.
  • Kunkel SL, Ogawa H, Ward PA, Zurier RB. Suppression of chronic inflammation by evening primrose oil. Prog Lipid Res. 1981; 20: 885-888.
  • Higgins JP, Altman DG, Gøtzsche PC, Jüni P, Moher D, Oxman AD, Savović J, Schulz KF, Weeks L, Sterne JA. The cochrane collaboration’s tool for assessing risk of bias in randomised trials. BMJ. 2011; 343: 1-9.
  • Krithikadatta J, Gopikrishna V, Datta M. A concept note on the need for standardized guidelines for improving quality and transparency in reporting in vitro studies in experimental dental research. J Conserv Dent. 2014; 17(4): 301-304.
  • Hooijmans CR, Rovers MM, De Vries RB, Leenaars M, Ritskes-Hoitinga M, Langendam MW. SYRCLE’s risk of bias tool for animal studies. BMC Med Res Methodol. 2014; 14: 1-9.
  • Leventhal LJ, Boyce EG, Zurier RB. Treatment of rheumatoid arthritis with gammalinolenic acid. Ann Intern Med. 1993; 119(9): 867-873.
  • McInnes IB, Schett G. The pathogenesis of rheumatoid arthritis. N Engl J Med. 2011; 365(23): 2205-2219.
  • Hemdan NY, Birkenmeier G, Wichmann G, El-Saad AMA, Krieger T, Conrad K, Sack U. Interleukin-17-producing T helper cells in autoimmunity. Autoimmun Rev. 2010; 9(11): 785-792.
  • Matsuno H, Yudoh K, Katayama R, Nakazawa F, Uzuki M, Sawai T, Yonezawa T, Saeki Y, Panayi GS, Pitzalis C, Kimura T. The role of TNF‐α in the pathogenesis of inflammation and joint destruction in rheumatoid arthritis (RA): a study using a human RA/SCID mouse chimera. Rheumatology. 2002; 41(3): 329-337.
  • Buchan G, Barrett K, Turner M, Chantry D, Maini RN, Feldmann M. Interleukin-1 and tumour necrosis factor mRNA expression in rheumatoid arthritis: prolonged production of IL-1 alpha. Clin Exp Immunol. 1988; 73(3): 449-455.
  • Nishimoto N, Ito A, Ono M, Tagoh H, Matsumoto T, Tomita T, Ochi T, Yoshizaki K. IL-6 inhibits the proliferation of fibroblastic synovial cells from rheumatoid arthritis patients in the presence of soluble IL-6 receptor. Int Immunol. 2000; 12(2): 187-193.
  • Kim KW, Kim BM, Moon HW, Lee SH, Kim HR. Role of C-reactive protein in osteoclastogenesis in rheumatoid arthritis. Arthritis Res Ther. 2015; 17(1): 1-12.
  • Levin G, Duffin KL, Obukowicz MG, Hummert SL, Fujiwara H, Needleman P, Raz A. Differential metabolism of dihomo-gamma-linolenic acid and arachidonic acid by cyclo-oxygenase-1 and cyclo-oxygenase-2: implications for cellular synthesis of prostaglandin E1 and prostaglandin E2. Biochem J. 2002; 365(Pt 2): 489-496.
  • Timoszuk M, Bielawska K, Skrzydlewska E. Evening primrose (Oenothera biennis) biological activity dependent on chemical composition. Antioxidants. 2018; 7(8): 1-11.
  • de Lima-Salgado TM, Alba-Loureiro TC, do Nascimento CS, Nunes MT, Curi R. Molecular mechanisms by which saturated fatty acids modulate TNF-α expression in mouse macrophage lineage. Cell Biochem Biophys. 2011; 59(2): 89-97.
  • Higgins AJ, Lees P. The acute inflammatory process, arachidonic acid metabolism and the mode of action of anti-inflammatory drugs. Equine Vet J. 1984; 16(3): 163-175.
  • Seven A, Güzel S, Aslan M, Hamuryudan V. Lipid, protein, DNA oxidation and antioxidant status in rheumatoid arthritis. Clin Biochem. 2008; 41(7): 538-543.
  • Pająk P, Socha R, Broniek J, Królikowska K, Fortuna T. Antioxidant properties, phenolic and mineral composition of germinated chia, golden flax, evening primrose, phacelia and fenugreek. Food Chem. 2019; 275: 69-76.
Research Journal of Pharmacognosy
Volume 11, Issue 2
April 2024
Pages 71-79

Files

Share

How to cite

Statistics